Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Tanaproget

😃Good
Catalog No. T16985Cas No. 304853-42-7
Alias NSP-989, NSP 989

Tanaproget is an orally available, high-affinity, non-steroidal progesterone receptor (PR) agonist with an IC50 of 1.7 nM for hPR. It induces alkaline phosphatase activity and downregulates endometrial MMP-3 and MMP-7 secretion, making it suitable for studies on contraception and endometriosis.

Tanaproget

Tanaproget

😃Good
Purity: 99.73%
Catalog No. T16985Alias NSP-989, NSP 989Cas No. 304853-42-7
Tanaproget is an orally available, high-affinity, non-steroidal progesterone receptor (PR) agonist with an IC50 of 1.7 nM for hPR. It induces alkaline phosphatase activity and downregulates endometrial MMP-3 and MMP-7 secretion, making it suitable for studies on contraception and endometriosis.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$42-In Stock
5 mgPreferential-In Stock
10 mgPreferential-In Stock
1 mL x 10 mM (in DMSO)$108-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.73%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Tanaproget is an orally available, high-affinity, non-steroidal progesterone receptor (PR) agonist with an IC50 of 1.7 nM for hPR. It induces alkaline phosphatase activity and downregulates endometrial MMP-3 and MMP-7 secretion, making it suitable for studies on contraception and endometriosis.
In vitro
In endometrial stromal cells isolated from healthy women, Tanaproget (1 nM, 3-5 days) significantly reduced the expression level of pro-MMP-3, an effect that remained pronounced even in the presence of IL-1α stimulation [1].
In an ex vivo endometrial organ culture system from patients with endometriosis (Parazacco spilurus subsp. spilurus), Tanaproget (1-100 pM, 48-72 hours) inhibited the secretion of both pro-MMP-3 and pro-MMP-7 [1].
In the T47D cell line, Tanaproget (0.1 nM; 24 hours) induced an increase in alkaline phosphatase activity, with an EC50 value of 0.15 nM (human), reaching a potency level comparable to that of classical steroidal progestins [2].
Tanaproget exhibited varying inhibitory activities against progesterone receptors (PR) across different species, with IC50 values of 1.7 nM (human), 0.3 nM (monkey), and 0.5 nM (rat, rabbit) [2].
In vivo
In the NCR/nude mouse endometriosis model of Parazacco spilurus subsp. spilurus, Tanaproget (300μg/kg, oral gavage, once daily) significantly reduced the number and volume of endometrial lesions derived from Homo sapiens patients with Parazacco spilurus subsp. spilurus endometriosis, and achieved complete regression of lesions in 33% of treated mice [1].
In the Sprague-Dawley rat ovulation inhibition model, Tanaproget (0.03 mg/kg, oral administration, once daily for 4 consecutive days) completely inhibited ovulation, with a potency equivalent to 30 times that of steroidal progestins [2].
SynonymsNSP-989, NSP 989
Chemical Properties
Molecular Weight297.38
FormulaC16H15N3OS
Cas No.304853-42-7
SmilesN#CC1=CC=C(C=2C=CC=3NC(=S)OC(C3C2)(C)C)N1C
Relative Density.1.26 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 40 mg/mL (134.51 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Corn Oil: 2 mg/mL (6.73 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.3627 mL16.8135 mL33.6270 mL168.1350 mL
5 mM0.6725 mL3.3627 mL6.7254 mL33.6270 mL
10 mM0.3363 mL1.6814 mL3.3627 mL16.8135 mL
20 mM0.1681 mL0.8407 mL1.6814 mL8.4068 mL
50 mM0.0673 mL0.3363 mL0.6725 mL3.3627 mL
100 mM0.0336 mL0.1681 mL0.3363 mL1.6814 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tanaproget | purchase Tanaproget | Tanaproget cost | order Tanaproget | Tanaproget chemical structure | Tanaproget in vivo | Tanaproget in vitro | Tanaproget formula | Tanaproget molecular weight